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Abstract 
Both lesions of endodontic origin and periodontal diseases involve the host response to bacteria and the 
formation of osteolytic lesions. Important for both is the upregulation of inflammatory cytokines that 
initiate and sustain the inflammatory response. Also important are chemokines that induce recruitment of 
leukocyte subsets and bone-resorptive factors that are largely produced by recruited inflammatory cells. 
However, there are differences also. Lesions of endodontic origin pose a particular challenge since that 
bacteria persist in a protected reservoir that is not readily accessible to the immune defenses. Thus, 
experiments in which the host response is inhibited in endodontic lesions tend to aggravate the formation 
of osteolytic lesions. In contrast, bacteria that invade the periodontium appear to be less problematic so 
that blocking arms of the host response tend to reduce the disease process. Interestingly, both lesions of 
endodontic origin and periodontitis exhibit inflammation that appears to inhibit bone formation. In 
periodontitis, the spatial location of the inflammation is likely to be important so that a host response that 
is restricted to a subepithelial space is associated with gingivitis, while a host response closer to bone is 
linked to bone resorption and periodontitis. However, the persistence of inflammation is also thought to 
be important in periodontitis since inflammation present during coupled bone formation may limit the 
capacity to repair the resorbed bone. 
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Both lesions of endodontic origin and periodontal diseases involve the host response to bacteria and the
formation of osteolytic lesions. Important for both is the upregulation of inflammatory cytokines that initiate
and sustain the inflammatory response. Also important are chemokines that induce recruitment of leukocyte
subsets and bone-resorptive factors that are largely produced by recruited inflammatory cells. However,
there are differences also. Lesions of endodontic origin pose a particular challenge since that bacteria persist in
a protected reservoir that is not readily accessible to the immune defenses. Thus, experiments in which the host
response is inhibited in endodontic lesions tend to aggravate the formation of osteolytic lesions. In contrast,
bacteria that invade the periodontium appear to be less problematic so that blocking arms of the host response
tend to reduce the disease process. Interestingly, both lesions of endodontic origin and periodontitis exhibit
inflammation that appears to inhibit bone formation. In periodontitis, the spatial location of the inflammation
is likely to be important so that a host response that is restricted to a subepithelial space is associated with
gingivitis, while a host response closer to bone is linked to bone resorption and periodontitis. However, the
persistence of inflammation is also thought to be important in periodontitis since inflammation present during
coupled bone formation may limit the capacity to repair the resorbed bone.
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P
eriapical lesions of endodontic origin and period-
ontitis are two common conditions found in the
oral cavity that share pathologic mechanisms
involving interactions between immune cells and bone.
Lesions of endodontic origin are associated with bacterial
contamination and necrosis of the dental pulp, which
typically progress through four stages: (1) exposure of the
dental pulp to the oral cavity with subsequent bacterial
colonization, (2) inflammation and necrosis of the dental
pulp, (3) the development of inflammation in the
periapical area, and (4) periapical resorption of bone
and formation of granulomas or cysts. Osteolytic lesions
in periodontitis are initiated by bacterial plaque in the
gingival sulcus and on the tooth surface. Periodontitis
similarly occurs in four stages: (1) bacterial accumulation
of a biofilm and presence in the gingival sulcus (coloniza-
tion), (2) bacterial penetration of epithelium and
connective tissue in the gingiva adjacent to tooth surface
(invasion), (3) stimulation of a host response that involves
activation of the acquired and innate immune response
(inflammation), and (4) destruction of connective tissue
attachment to the tooth surface and bone that is
irreversible (irreversible tissue loss). Both oral diseases
demonstrate similar patterns of development, bone
resorption associated with bacteria that adhere to and
invade soft tissue stimulating an inflammatory response
and subsequent osteoclastogenesis.
Lesions of endodontic origin
Endodontic lesions typically develop from exposure of
the pulpal tissue to oral bacteria as a result of deficiencies
in the integrity of a tooth. This may result from carious
lesions that dissolve the mineralized dental tissue, frac-
tures of the tooth structure, as well as iatrogenic and
other circumstances that allow bacteria to penetrate into
the pulpal tissues. In most cases, these events lead to
infection within the dental pulp, which causes the
development of inflammation that spreads from the
exposed area. The inflammation is often followed by
pulpal tissue necrosis, leading to chronic infection, the
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spread of inflammation to the tooth apex, and bone
resorption. The inflammatory response involves the
recruitment and activation of leukocytes of both the
innate and adaptive immune responses, with resultant
osteoclastogenesis and formation of an osteolytic lesion
at the apex of the tooth.
Inflammation and resorption of bone at the tooth
apex, in most cases, is a consequence of the interaction
between microbial infection and the host response. The
critical role of bacteria in the development of periapical
lesions has been demonstrated by mechanical exposure of
the dental pulp to the oral cavity in germ-free animals. In
these germ-free animals, pulp exposure heals with an
initial or transitory inflammatory response within the
pulpal tissue, followed by a reparative response from
pulpal cells, and leading to the formation of a new dentin-
like matrix bridging the exposed site. In contrast,
mechanical pulp exposure in animals with normal oral
bacteria causes an infection of the dental pulp, with
pulpal tissue necrosis and chronic infection that prevents
the repair process (1). The infection persists as the
necrotic tissue of the dental pulp is inaccessible to
leukocytes and, hence, represents a protected reservoir
of bacteria (2, 3). The chronic inflammation stimulated
by bacteria and their products in the periapical area of
the tooth leads to localized bone resorption that is
‘uncoupled’ so there is no reparative bone formation
without treatment. The result is formation and expansion
of granulomas or cysts in the apical tissues (4).
Understanding the pathogenic mechanisms underlying
the development of endodontic lesions is confounded by
the persistence of a ‘bacterial reservoir’ that exists in the
pulp canal and necrotic tissue. The bacterial presence
stimulates an inflammatory response to resist infection.
During this response a number of cell types present
release cytokines, chemokines, leukotrienes, and prosta-
glandins into the area. These inflammatory mediators
reinforce the recruitment of polymorphonuclear leuko-
cytes (PMNs) and other leukocytes, creating an interest-
ing dichotomy of activity and consequences as to the
essential protective or destructive roles mediated (3). As
would be expected, the host response plays a critical and
protective role in lesions of endodontic origin in limiting
the spread of infection into the fascial planes. Consistent
with this expectation, specific inhibitors of inflammatory
cytokines tend to cause the formation of larger osteolytic
lesions since they compromise the ability of the host to
protect itself from the reservoir of bacteria in the necrotic
pulp. This increase in lesion dimensions occurs even
though the blocked inflammatory cytokines also play an
important role in osteoclastogenesis. The use of inhibitors
or mice with targeted genetic deletions may not necessa-
rily reveal the role of a particular cytokine or cell type
that plays an important role in activating osteoclastogen-
esis since its inhibition or knockout may also increase
susceptibility to bacterial infection. If the impact on
resistant infection is greater, the larger lesion will be
produced even though direct effect on deletion or
inhibition should reduce osteoclast formation. The re-
verse is also true. For example, an enhanced host
response in an animal model for periapical endodontic
lesions demonstrates increased numbers of PMNs and
monocytes with a reduction in the extent of apical bone
resorption, even though the host response may contribute
to the bone resorption (5). In another example, the
deletion of tumor necrosis factor (TNF) or IL-1 receptor
signaling causes larger osteoclast lesion formation even
though both cytokines stimulate bone resorption. This
occurs because deletion of TNF or IL-1 signaling impairs
the antibacterial activity of the host response that is
critical in lesions of endodontic origin (6). In particular,
IL-1 receptor signaling is needed to prevent the spread of
infection from necrotic pulp into fascial planes and to
protect the host from significant morbidity and mortality
that would result (6). Thus, there is considerable complex-
ity in examining the impact of cytokine signaling since
cytokines have both destructive roles as well as an
important protective function in antibacterial defense (6).
The control of the periapical infection seems to be a
critical aspect of this process, since the absence of the
pleiotropic enzyme inducible nitric oxide synthase (iNOS)
also results in larger lesions with the recruitment of a
greater number of inflammatory cells and frequently
associated with periapical abscesses development (7).
This contrasts with periodontal disease, in which a
protected bacterial reservoir does not exist and the use
of inhibitors or mice with targeted deletions of the host
response typically do not compromise the antibacterial
defenses sufficiently to complicate the analysis. Thus,
lesions of endodontic origin appear to be at an increased
susceptibility to bacterial infection with inhibition of the
host response in contrast to periodontal disease.
Leukocytes and endodontic lesions
The initiation of an inflammatory cascade in lesions of
endodontic origin includes the complex interplay of
multiple cell types involving the activation of endothelial
cells, PMNs, macrophages, lymphocytes, and osteoclasts
leading to rapid bone destruction. The complex host
response involves cells of both the innate and adaptive
immune response. The rapid destruction of bone found
with endodontic lesions is initiated by multiple bacteria
or their products including lipopolysaccharides (LPSs)
(3). Bacteria are thought to stimulate resorption through
the induction of proinflammatory cytokines such as IL-
1b, IL-1a, receptor activator of nuclear factor kappa-B
ligand (RANKL), or TNF-a (8, 9). The initial activation
of the host response occurs through stimulation of toll-
like receptors (TLRs) and nucleotide-binding oligomer-
ization domain (NOD) receptors (10). Both TLRs and
Dana T. Graves et al.
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NODs are highly expressed on multiple cell types
associated with the endodontic lesions including mono-
cytes/macrophages, granulocytes, pulp fibroblasts, osteo-
clast precursors, and mesenchymal cells (10, 11).
Activation of these receptors leads to the stimulation of
multiple proinflammatory cytokines, including IL-1,
TNF-a, and IL-6, and has been associated with enhanced
RANKL production, osteoclastogenesis, and bone re-
sorption (10, 11).
Multiple studies have reinforced the concept that the
development of bone resorption in lesions of endodontic
origin involves the adaptive immune response. The
predominant cell types in endodontic lesions in a rat
model were shown to be T-cells followed by B-cells and
monocytes/macrophages (12). Multiple T-cell responses
have been associated with endodontic lesions, including
Th1 (IL-2 and IFN-g), Th2 (IL-4 and IL-5), T-regulatory
cells (Tregs; IL-10 and TGF-b), and Th17 (IL-17A)
lymphocytes (1315). In fact, the key transcription
factors essential for Th1, Th2, and Tregs differentiation,
T-bet, GATA-3, and FOXp3, respectively, have been
found in periapical lesions (14) as well as IL-17A, the
prototypical cytokine produced by Th17 cells (13).
The importance of the adaptive immune response in
protecting the host during formation of endodontic
lesions has been demonstrated in numerous studies. The
exposure of the dental pulp in severe combined immu-
nodeficient (SCID) mice showed periapical lesions of
similar size to that found in normal control mice (16).
However, approximately one-third of the immunodefi-
cient mice with endodontic lesions developed orofacial
abscesses. Interestingly, two studies identified contrasting
results utilizing nu/nu rats with a deficient T-cell response.
While one study showed greater bone resorption follow-
ing endodontic infections, suggesting a critical protective
role, the other study failed to identify a difference in the
amount of bone resorption (17, 18). Evidence of a
protective role for IFN-g, the prototypical Th1-cytokine,
was demonstrated as the absence of IFN-g resulted in
increased bone resorption compared to wild-type mice
(19). Emerging evidence suggests that the majority of
Th17 cells also express IFN-g, supporting a role for both
Th1 and Th17 proinflammatory responses in the patho-
genesis of periapical periodontitis (13). An examination
of the Th2 response with genetic deletion of IL-4 failed to
identify an effect, suggesting more complex redundancies
or that Th2 responses are not critical in protection or
bone resorption (19). However, the anti-inflammatory
cytokine IL-10 has been demonstrated to be a protective
factor against periapical bone resorption. Periapical
lesions in mice with genetic ablation of IL-10 were
increased in size compared with wild-type mice, consis-
tent with a protective role for IL-10 (19). Furthermore,
IL-10 mRNA levels in human periapical granulomas have
been positively correlated with the expression of proteins,
SOCS1 and SOCS3, which act as negative regulators of
the inflammatory signaling (20). Interestingly, Tregs, as a
potential source of IL-10, were found in the periapical
lesions following endodontic infection consistent with a
regulatory role in lesion development (15, 21).
Cytokines
The initial rapid destruction of bone in the apical area of
the root has been associated with the production of
prostaglandins, in particular PGE2, through the cycloox-
ygenase pathway (22). These findings provide clarifica-
tion to an earlier report that indomethacin reduces the
extent of bone resorption in endodontic lesions (23).
Endodontic lesions have been associated with multiple
proinflammatory cytokines and chemokines. Cytokines
that participate in the formation of osteolytic lesions are
shown in Figs. 1 and 2. Interleukins (IL), particularly IL-
1a and IL-b are produced in periapical lesions by several
types of cells including macrophages, osteoclasts, PMNs,
and fibroblasts (24, 25). The role for IL-1 in stimulating
periapical bone destruction was demonstrated using
interleukin-1 receptor antagonists to show a 60% reduc-
tion in lesion development (26). It appears that much of
the induced osteoclastogenic activity in periapical lesions
is specifically related to the formation of interleukin-1a
(27). However, when IL-1 receptor signaling is completely
deleted there is increased lesion size and systemic
morbidity (5). In addition, TNF-a expression has been
identified in lesions of endodontic origin by cells such as
PMNs, monocytes/macrophages, and fibroblasts and
may contribute to lesion formation (3). The IL-6 has
been observed in exudates from human periapical lesions,
with osteoblasts, fibroblasts, macrophages, PMNs, and
T lymphocytes identified as expressing IL-6 protein (28,
29). IL-6 has been shown to play a protective role since
endodontic lesions in IL-6 deficient animals are increased
in size compared with control mice (30). The role of
cytokines in formation of endodontic and periodontal
osteolytic lesions is shown in Tables 1 and 2.
Neutrophils are active in the development of bone loss
associated with endodontic lesions. This has been demon-
strated in animals with some neutropenia having a
considerable decrease in periapical lesion formation
(31). The recruitment of PMNs with chemokines has
also been implicated in the pathogenesis of periapical
lesions. IL-8/CXCL8 chemokine expression is prominent
in periapical lesions, consistent with heavy infiltration by
PMNs (32).
The recruitment of monocytes is critical in the
antimicrobial defense in lesions of endodontic origin.
Chemokines and chemokine receptors stimulate innate
and adaptive immunity in the periapical environment and
in the development of granulomas associated with these
lesions (33). Genetic deletion of MCP-1/CCL2, identified
in monocytes/macrophages and bone lining cells in
Review of osteoimmunology
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endodontic lesions, significantly reduces monocytic
infiltrate while increasing the amount of bone resorption
(34, 35). Similarly, the absence of the MCP-1 receptor
(CCR2) or genetic ablation of CC chemokine receptor
five (CCR5) results in an increased amount of apical
bone resorption and is associated with higher levels of the
Fig. 1. RANKL/OPG balance is an important factor in regulating bone resorption in periodontal and periapical environments.
Osteoclast differentiation and activation are driven by the interaction of RANK (receptor activator of nuclear factor-kB) with
its ligand, RANKL. Osteoprotegerin, OPG, is a decoy receptor of RANKL that inhibits RANK-RANKL engagement. In
homeostatic conditions (left side), RANKL and OPG levels are thought to be in balance so that there is limited
osteoclastogenesis and bone resorption. With an inflammatory stimulus, the RANKL/OPG ratio increases in periodontal
and periapical tissues and leads to stimulation of osteoclast activity and pathologic bone resorption.
Fig. 2. Cytokine regulation of matrix degradation and bone resorption in periodontal and periapical environments. The
presence of microbial pathogens in periodontal and periapical environments trigger an initial production of proinflammatory
cytokines, such as TNF-a and IL1b, which stimulate expression and activation of matrix metalloproteinases (MMPs) that
degrade extracellular connective tissue matrix. Cytokines such as TNF-a can stimulate osteoclastogenesis independently while
other cytokines stimulate RANKL expression that leads to formation of osteoclasts and osteoclast activity. The combined
innate and adaptive immune responses are likely to lead to the high levels of inflammation and bone resorption. These
proinflammatory cytokines are thought to generate an amplification loop that contributes to periodontal and periapical lesion
progression. Conversely, cytokines produced by Th2 cells and Tregs, such as IL-4 and IL-10 have the opposite effect, in part,
through stimulating production of tissue inhibitors of matrix metalloproteinases (TIMPs) and OPG as well as restrain
inflammatory cytokine production.
Dana T. Graves et al.
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osteolytic factors, such as RANKL and cathepsin K (19,
36). Interestingly, activation of the MCP-1/CCL2-CCR2
axis appears to play an active role in mediating the
migration of monocytes/macrophages while limiting the
infiltration of PMNs (36).
The RANKL and osteoprotegerin (OPG) expression
demonstrate a heterogeneous pattern in periapical gran-
ulomas, ranging from a high ratio of RANKL to OPG
consistent with bone resorption to a low ratio seen in sites
with minimal bone resorption (37). These disparate
findings in levels of RANKL/OPG ratio may be indica-
tive of an expanding lesion with active bone resorption or
a stable lesion with minimal bone resorption (37, 38). A
description of the role of the RANK-OPG axis in
stimulating osteoclastogenesis and bone resorption is
shown in Fig. 1.
Periodontal diseases
The periodontium is a complex set of tissues that are in
close proximity with a complex biofilm harboring diverse
and numerous bacterial species (39, 40). Periodontal
diseases include gingivitis and periodontitis. While it is
a consensus that periodontal diseases are stimulated
by bacterial adherence to the tooth surface, there is
controversy about which bacteria stimulate the irrever-
sible breakdown of periodontal tissues in periodontitis
(40, 41). Recent evidences from studies that do not rely
upon bacterial culture techniques suggest that there are
Table 1. Cytokine effects on bone lesions associated with endodontic or periapical lesions
Cytokine Effect of deletion or
inhibition Effect of cytokine on osteoclasts Other effects of cytokine
IL-1a Reduction in lesion size Increase in immature osteoclasts and
increase resorption by osteoclasts
Increased levels of MMP’s 1, 3, 9, and 13
IL-1b Increase in lesion size Increased levels of immature osteoclasts
and increase resorption by osteoclasts
Increased expression of RANK, RANKL,
and MMP-9
IL-1 receptor Increased lesion size Increased morbidity and mortality from
endodontic infection
IL-2 Increase in lesion size Unknown Promotes T-cell growth and expansion
and CMI
IL-4 No effect on lesion size Suppresses osteoclast differentiation and
osteoclast bone resorption
Promotes differentiation of CD4 T-cells
into TH2s
TNF-a No effect on lesion size Induces osteoclast differentiation,
osteoclastogenesis, and bone resorption
Proinflammatory effects, promotes CMI
TNF receptor Increased lesion size Greater osteoclast activity and formation
when deleted due to lack of protection
IL-6 Increase in lesion size Increase in number of osteoclasts and
increase resorption
Anti-inflammatory effects, stimulates
release of acute phase proteins




IL-10 Deletion results in
increase in lesion size
No effect on osteoclast number, inhibits
osteoclastogenesis
Promotes PMN infiltration
MCP-1 Increase in lesion size Stimulates recruitment of precursors Stimulates protective monocyte/
lymphocyte recruitment
IL-17 Reduced lesion size Increased levels associated with
decreased numbers of osteoclasts
Stimulates monocyte/lymphocyte
recruitment
INF-g No effect on lesion size
Reduced levels of IL-6, IL-10,
IL-12, TNF-a
Decreases osteoclastogenesis Promotes CMI
IL-12 No effect on lesion size Decreases TNF-a and RANKL induced
osteoclastogenesis
Increases IL-18
IL-18 No effect on lesion size Decreases TNF-a induced
osteoclastogenesis
Increases IL-12
Nitric Oxide Increase in lesion size Unknown Induces IL-8, RANK production,
macrophage, and osteoblast apoptosis
Review of osteoimmunology
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approximately 700 bacterial species in the oral cavity (39).
As a general rule, the bacteria that might cause period-
ontitis have classically been identified as gram-negative
anaerobic bacteria that survive in the gingival sulcus, the
space between the tooth surface and the adjacent gingival
epithelium (42). Much attention has been spent on
Aggregatibacter actinomycetemcomitans and Porphyromo-
nas gingivalis, which have been linked to localized
aggressive ‘juvenile periodontitis’ and ‘adult periodonti-
tis’, respectively (42, 43). However, recent approaches to
bacterial identification have suggested that a reevaluation
of pathogenic species is warranted.
The presence of periodontal pathogens is required but
not sufficient for disease initiation. In fact, studies clearly
demonstrate that cytokines induced by the host response
play a critical role in periodontal tissue breakdown (44
47). Host-microbe interactions start in the gingival
epithelium and stimulate an inflammatory response that
confers efficient protection against bacteria (i.e. the
systemic consequences of acute infection are rare).
However, the host mediator release results in a clinical
outcome represented by the onset of gingivitis. Because
the gingival epithelium and underlying connective tissue
are chronically exposed to bacteria or their products,
both the innate and the acquired immune response are
chronically activated in connective tissue adjacent to
epithelium lining the gingiva. In most cases, tissue
destruction caused by activation of the host response is
reversible and associated with gingivitis. On the other
hand, under certain conditions that are not fully under-
stood, the disease can progress and cause destruction of
the underlying connective tissue attachment of the
gingiva toward the tooth surface and from tooth to
bone. Indeed, periodontitis is distinguished from gingivi-
tis by the irreversible nature of the attachment loss. One
of the most important uncertainties regarding period-
ontitis is its chronic nature. Periodontitis may represent a
series of brief insults, or ‘bursts’, which accumulate and
appear to be chronic over time with extended periods of
remission. However, the length of time of the ‘burst’ is
unknown. Alternatively, there may be relative constant
stimulation over time, but it is not known how long the
chronic destructive period lasts in the chronic model. In
spite of evidences for both models (4850), the nature of
periodontal disease progression remains uncertain. This
problem has plagued human studies since it is difficult to
know whether an individual is undergoing active period-
ontal breakdown at any given point in time. Furthermore,
the relative absence of longitudinal studies has made the
interpretation of results with human patients difficult
since relationships between a given variable and irrever-
sible periodontal breakdown are difficult to establish in
cross-section studies.
Animal models have established a clear causal relation-
ship between bacteria and periodontitis. In an animal
model, a ligature is tied around the teeth allowing plaque
accumulation and bacterial penetration, which leads to
subsequent inflammation and alveolar bone resorption
(51). In fact, gnotobiotic rats treated identically do not
exhibit periodontal bone loss (52), demonstrating the
essential role of bacteria in this model. Additional
evidence is provided by the treatment with antibiotics
or topical application of antimicrobial agents, which
reduce bone resorption in the ligature model, while
increased colonization by gram negative bacteria en-
hances bone resorption (51). In other animal models,
the inoculation of periodontal pathogens into the oral
cavity of rodents induces bone loss. In several studies, the
introduction of P. gingivalis by oral lavage stimulates
alveolar bone resorption (51). Similarly, introduction of
A. actinomycetemcomitans in rodents leads to coloniza-
tion and loss of the alveolar bone (43, 51). Thus,
experiments with animal models support human studies
demonstrating the role of bacteria in inflammation onset
and periodontitis.
Since the presence of bacteria is required, but not
sufficient to trigger periodontitis development, the re-
cognition of microbial components as ‘danger signals’ by
host cells and the subsequent production of inflamma-
tory mediators is an essential step in periodontitis
pathogenesis. Indeed, one of the critical components of
the host response to bacteria or their products is a family
of receptors called the toll-like receptors (TLRs). The
TLRs activate the innate immune response binding to
various microbial components (i.e. diacyl lipopeptides,
peptidoglycan, LPS, flagellin, bacterial DNA, etc.) (53).
After TLR activation, an intracellular signaling cascade
Table 2. Comparison of inflammatory component roles in
bone resorption
Deletion/inhibition effects on bone
resorption (lesion size)a
Inflammatory component Endodontic Periodontal
IL-1 Reduced Reduced
IL-1 receptor Increasedb Not tested
TNF-a No effect Reduced





B- and T-cell (SCID mice) No effectb Reduced
IL-17 No effect Increased
aIncreased bone resorption is consistent with protective effects;
reduced resorption consistent with a net destructive effect.
bWith increased morbidity/mortality noted.
cBased on clinical findings of immunodeficiencies.
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leads to the activation of transcription factors, such as
nuclear factor-k B (NF-kB), activator protein-1 (AP-1),
and subsequent production of various cytokines
and chemokines (53). Recent studies describe a role
for both TLR-2 and TLR-4 in the recognition of
A. actinomycetemcomitans, whose impact range from
stimulating inflammatory cytokine expression and in-
flammatory cell migration to inducing osteoclastogenesis
and alveolar bone loss (54, 55). Besides TLRs, the
nucleotide-binding oligomerization domain (NOD) re-
ceptors and the inflammasome system have been pointed
out as potential accessory molecules that trigger the host
response against periodontal pathogens (56).
Animal models also provided the initial clear evidences
for the role of some host immune inflammatory factors in
the progression of periodontal diseases. When the host
response is altered by treatment with specific inflamma-
tory inhibitors or genetic manipulation, the severity of
periodontal connective tissue and bone loss stimulated by
periodontal bacteria is clearly reduced. The first concrete
evidence that inhibition of an inflammatory response
reduces periodontal diseases was carried out in a dog
model (57) in which the inhibition of prostaglandins
significantly reduced alveolar bone loss. Subsequent
studies have used a number of techniques to demonstrate
that cytokines play an important role in periodontitis.
Non-human primates treated with inhibitors to two
major proinflammatory cytokines, IL-1 and TNF, exhibit
reduced periodontal bone loss and loss of attachment
compared to control animals (44, 45, 58). Similarly,
RANKL inhibition decreases alveolar bone loss in
several models of periodontal disease (46, 59, 60). It is
hypothesized that periodontal disease progression is due
to a combination of several factors, including the
presence of periodontopathic bacteria, high levels
of proinflammatory cytokines and prostaglandins, the
production and activation of MMPs and RANKL, and
relatively low levels of interleukin-10 (IL-10), transform-
ing growth factor-b (TGF-b), tissue inhibitors of metal-
loproteinase (TIMPs), and osteoprotegerin (OPG) (61).
A description of inflammatory cytokines and cell types
that participate in bone resorption and destruction of
connective tissue matrix is shown in Fig. 2.
Inflammatory mediators
The cyclooxygenase enzymes, COX-1 and COX-2, cata-
lyze the conversion of arachidonic acid to prostaglandins.
COX-1 is constitutively expressed and leads to the
generation of prostaglandins that are particularly im-
portant in homeostasis. COX-2 is inducible and leads to
the formation of prostaglandins involved in inflammatory
processes. Prostaglandins (PGs), potent stimulators of
bone formation and resorption, are produced by bone
cells, fibroblasts, gingival epithelial cells, endothelial cells,
and inflammatory cells (62). Prostaglandin E2 produc-
tion is elevated in individuals with periodontitis com-
pared with healthy subjects (63). When applied topically
to the gingival sulcus, prostaglandin E2 induces a marked
increase in osteoclasts. Moreover, it is synergistic with
lipopolysaccharide stimulating osteoclastogenesis (64).
Both PGE-2 and leukotriene B-4 were found in
gingival crevicular fluid of individuals with localized
aggressive periodontitis. Furthermore, P. gingivalis
stimulates increased PGE-2 levels and increased COX-2
expression by infiltrated leukocytes in vivo (65). In an
animal ligature induced periodontitis model, both a non-
selective COX inhibitor and a selective COX-2 inhibitor
reduced osteoclast numbers and alveolar bone loss when
compared to non-treatment (66). Many clinical trials
have explored the use of a COX-2 inhibitor as an adjunct
to periodontal therapy. These inhibitors improved the
clinical outcome after periodontal therapy compared to
periodontal therapy alone (67). However, they are not
clinically used in the treatment of human patients due to
side effects. Lipoxins and resolvins, products of omega-3
fatty acids, induce resolution of inflammation, and to
protect against periodontal bone loss stimulated by
bacteria in animal models (68).
The induction of experimental periodontitis is asso-
ciated with the expression of innate immune cytokines
(69). IL-1 stimulates the expression of proresorptive
cytokines, such as RANKL and TNF-a and proteinases
that participate in periodontal connective tissue destruc-
tion and bone resorption. In the periodontium, IL-1 is
produced by several types of cells including PMNs,
monocytes, and macrophages (70, 71). In patients with
periodontitis, IL-1b expression is elevated in gingival
crevicular fluid at sites of recent bone and attachment
loss (71, 72). The IL-1b is also found to be higher in
gingiva from individuals with a history of periodontitis
than in samples from healthy individuals (72).
Using a non-human primate model, Delima et al.
showed that IL-1 inhibition significantly reduced inflam-
mation, connective tissue attachment loss, and bone
resorption induced by periodontal pathogens when
compared to controls (45). In other studies, IL-1 receptor
deficient mice had less P. gingivalis LPS-induced osteo-
clastogenesis compared to similarly treated wild-type
mice (73). In a different approach, the exogenous
application of recombinant human IL-1b in a rat model
of experimental periodontitis accelerated alveolar bone
destruction and inflammation over a 2-week period (74).
In addition, transgenic mice overexpressing IL-1a in
gingival epithelium developed a periodontitis-like syn-
drome, leading to the loss of attachment and destruction
of periodontal bone (75). Taken together, these studies
strongly support the role of IL-1 in promoting alveolar
bone destruction in periodontitis.
The TNF refers to two associated proteins, TNF-a and
TNF-b. TNF-a levels are upregulated in gingival crevi-
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cular fluid at sites where bone and attachment loss have
recently occurred (71, 7678). TNF-a was also found to
be higher in diseased periodontal tissue samples than in
tissue samples from healthy individuals (72). A cause and
effect relationship between TNF-a and periodontal bone
loss has been demonstrated. Administration of recombi-
nant TNF-a accelerates periodontal destruction in a rat
periodontitis model (79). On the other hand, P. gingivalis
induced osteoclastogenesis is reduced in TNF receptor-
deficient mice compared to wild-type controls, indicating
that osteoclast formation is dependent on TNF-a regu-
lated pathway as part of the host response to bacterial
challenge (80). Garlet et al. recently showed that TNFR-1
knockout mice developed significantly less inflammation,
indicated by chemokine and chemokine receptors down-
regulation, and less alveolar bone loss in association with
RANKL downregulation in response to A. Actinomyce-
temcomitans oral inoculation (81). Furthermore, mRNA
levels of IL-1b, IFN-g, and RANKL in gingival tissues
were significantly lower in TNFR-1 knockout mice than
in wild-type infected mice. In contrast, A. actinomyce-
temcomitans levels quantified by real-time PCR were
significantly greater in TNF receptor ablated mice than
in wild-type controls and were associated with lower
levels of the PMN-related antimicrobial mediator mye-
loperoxidase in experimental mice (81). Thus, the absence
of TNFR-1 resulted in a lower production of cytokines in
response to A. actinomycetemcomitans infection even in
the presence of higher levels of periodontal pathogens.
Based on similar studies, it can be implied that the local
production of TNF-a plays a role in upregulating the
host response to bacteria and stimulating bone resorption
during periodontitis. It is also possible that oral bacteria
in addition to causing local pathology may contribute to
systemic conditions by enhancing cytokine production
subsequent to bacteremias. Interestingly, P gingivalis LPS
stimulates a strong local inflammatory response but a
weak systemic inflammatory response (82). Inhibition of
IL-1 and TNF-a together significantly reduces the
progression of inflammation toward bone, osteoclasto-
genesis, and periodontal tissue destruction (44). In the
gingiva, a higher expression of IL-6 is found in gingival
crevicular fluid and in the gingiva in mononuclear cells
and T-cells from periodontitis patients than in healthy
controls (83, 84). The LPS from the periodontal pathogen
A. actinomycetemcomitans induces IL-6 expression,
osteoclastogenesis, and bone loss (85). Oral inoculation
of P. gingivalis in mice with genetically deleted IL-6 have
decreased bone loss compared to wild-type mice, suggest-
ing that IL-6 contributes to the progression of bacteria-
induced bone loss (47).
After a host response triggered by microbial recogni-
tion, the spatial orientation of the subsequent leukocyte
infiltration into periodontal tissues is likely to contribute
to periodontal disease. Histologically, the inflammatory
infiltrate is observed even in the presence of minimal
clinical signs of inflammation, but when inflammation is
restricted to the connective tissue closest to the gingival
epithelium, gingivitis is present (86). However, in animal
models, when the inflammatory infiltrate moves closer to
bone, osteoclastogenesis is induced and periodontal bone
loss takes place (44). This suggests that the periodontal
Fig. 3. Spatial relationship between an inflammatory infiltrate and periodontal bone loss. In periodontitis, bacteria attach to the
tooth surface and invade the adjacent epithelium and connective tissue. This causes formation of an inflammatory infiltrate
indicated by the black arrows. If the inflammatory infiltrate is at a distance from bone (left panel), osteoclastogenesis is not
stimulated. However, if the infiltrate moves closer to bone (right panel), osteoclasts are induced and bone resorption occurs.
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disease development might be determined by the progres-
sion of the inflammatory infiltrate toward bone. The
impact of spatial location of the inflammatory infiltrate
on bone resorption is shown in Fig. 3.
Among the mediators potentially involved in leukocyte
diapedesis and subsequent spatial localization in period-
ontal environment, chemokines have been investigated
with special interest in the last decade. Chemokines are
small chemotactic cytokines that stimulate the recruit-
ment of inflammatory cells (33, 87). They are divided into
two major families based on their structure, CC and CXC
chemokines, which basically bind to the two major classes
of receptors, CC chemokine receptors (CCR) and CXC
chemokine receptors (CXCR). Chemokines are produced
by several resident and inflammatory cell types in the
periodontium (33). Some chemokines can stimulate one
or more steps of bone resorption, including the recruit-
ment, differentiation, or fusion of precursor cells to form
osteoclasts or enhance osteoclast survival (33, 87). They
could also affect periodontal bone loss by recruiting cells,
such as neutrophils, which protect against bacterial
invasion.
Chemokines are found in gingival tissue and crevicular
fluid. The IL-8/CXCL8, a chemoattractant of PMNs, is
found at higher levels in gingival crevicular fluid prior to
clinical signs of inflammation following cessation
of tooth brushing. Moreover, in subjects with a history
of periodontitis, IL-8/CXCL8 in gingiva and gingival
crevicular fluid are increased and correlated with disease
severity (88).
One of the most abundant expressed chemokines is
macrophage inflammatory protein-1a (MIP-1a/CCL3),
which is localized in the connective tissue subjacent to
gingival epithelium (89). MIP-1a/CCL3-positive cells
increase with increasing severity of periodontal disease.
It is a ligand for the chemokine receptors CCR1 and
CCR5 and is associated with the recruitment of mono-
cytes/macrophages and dendritic cells via CCR1 and
lymphocytes polarized into Th1 phenotype by CCR5
(90). Thus, MIP-1a/CCL3 has a potential role in
stimulating bone resorption through effects on macro-
phages and Th1 cells. Moreover, CCR1 and CCR5
cell populations may affect resorption since they include
osteoclast precursors (91, 92). This is consistent with
findings that MIP-1a/CCL3 directly stimulates osteo-
clasts differentiation (93) and stromal-cell derived factor-
1 (SDF1/CXCL12) regulates osteoclast function and is
found in the periodontium (94).
A number of chemokines have been detected in gingiva
or in gingival crevicular fluid including regulated upon
activation normal T-cell expressed and secreted
(RANTES/CCL5). RANTES/CCL5 is found in greater
levels in active periodontal lesions compared to inactive
sites (89, 95). That RANTES/CCL5 may be involved in
periodontal bone resorption is supported by findings that
it binds to CCR1 and CCR5 (91, 96). Monocyte
chemoattractant protein-1 (MCP-1/CCL2) may also
contribute to periodontitis. MCP-1/CCL2 levels are
directly correlated with gingival inflammation (97, 98).
It stimulates monocyte/macrophage recruitment and
activity and has been implicated as a chemoattractant
for osteoclast precursors (91, 96).
RANKL stimulates osteoclastogenesis and bone
resorption. A number of studies have established that
RANKL inhibition decreases periodontal bone resorp-
tion (46, 59, 60) and establishes a role for RANKL in
periodontitis. Osteoprotegerin (OPG) is a molecule that is
also upregulated by inflammatory conditions and blocks
RANKL by binding to it. A high ratio of RANKL/OPG
creates proresorptive conditions while a low RANKL to
OPG ratio is antiresorptive. During bacteria stimulated
periodontal bone loss there is an initial increase in the
ratio of RANKL/OPG (69). After the initial bone loss,
antiresorptive factors are produced including OPG, as
well as IL-4 and IL-10, reducing the RANKL/OPG ratio
(69). This relationship is shown in Fig. 2. The RANKL/
OPG ratio has been examined in gingival tissues or
gingival crevicular fluid. It has been shown that period-
ontitis is associated with an increase in RANKL. The
RANKL/OPG ratio greater than 1 predominates in
chronic periodontitis lesions while a ratio of 0.5 or less
is found in chronic gingivitis lesions (37).
RANKL is upregulated in both pathologic and phy-
siologic bone resorption. In pathologic inflammatory
bone disease, RANKL expression has been shown to
have the highest level in B-cells, followed by T-cells, and
then monocytes (99). This indicates that activated T- and
B-cells can be the cellular source of RANKL for bone
resorption in diseased gingival tissue. In physiologic
bone, remodeling bone-lining cells such as osteoblasts
or their precursors appear to be an important source of
RANKL.
The IFN-g is a lymphokine, produced by lymphocytes
and natural killer cells that has been implicated in
periodontal bone loss. Its expression is associated with
Th1 lymphocytes. Mice with a genetic ablation of IFN-g
have less P. gingivalis induced bone loss compared to
wild-type controls (47). T-cells are an important source of
IFN-g in periodontitis (84) and have been linked to
increased RANKL expression (100).
Lymphocytes also produce cytokines that are anti-
inflammatory, such as IL-4 and IL-10 (101). These
cytokines are associated with a Th2 response and reduce
the severity of experimental periodontitis (102). However,
a direct link between Th1 lymphocytes enhancing period-
ontal disease and Th2 lymphocytes reducing it is not
necessarily straightforward since there are components of
a Th2 response that are also prodestructive (103).
Innate immune cells have been shown to play an
important role in periodontal bone resorption (61, 104).
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Monocytes and macrophages produce several cytokines
and lytic enzymes that stimulate the breakdown of
connective tissue and bone resorption (61). PMNs have
been shown to have both protective and destructive
effects (105). A protective role is inferred from findings
that neutrophil disorders including cyclic neutropenia,
Che´diak-Higashi syndrome, and leukocyte adhesion
deficiency syndrome promote periodontal diseases
(105). The production of reactive oxygen species and
cytokines implicates them in the destructive phase.
Monocytes and PMNs produce a respiratory burst that
generates superoxides, hydrogen peroxide, hydroxyl radi-
cals, hypochlorous acid, and chloramines. These products
contribute to bacterial killing based on evidence that
impaired production of iNOS and MPO are associated
with increased levels of periodontal pathogens (81, 106).
In addition, PMNs and monocytes/macrophages release
elastases and collagenases that break down connective
tissue (107) and are linked to the development of
periodontal lesions (107).
Dendritic cells of monocytic lineage are another group
of innate immune cells that function to present antigen to
lymphocytes and also promote inflammation by the
production of chemokines and cytokines (108). They
have been implicated in periodontal disease (108111).
Oral bacteria induce dendritic cells to produce cytokines
such as IL-1b, IL-12, IFN-g, TNF-a, and TNF-b (109,
110). Dendritic cells can form to osteoclasts (112). For
example, A. actinomycetemcomitans stimulates dendritic
cells in vitro to form osteoclasts in a RANKL dependent
manner (113).
Oral bacteria stimulate cells of the adaptive immune
response as shown by the presence of activated T- and B-
lymphocytes in periodontal disease tissues (61). As
discussed above, lymphocytes produce cytokines that
promote bone resorption directly through RANKL or
indirectly through IFN-g. There is evidence to suggest
that lymphocytes are involved in mediating bacteria
stimulated periodontal bone resorption. When severe
combined immunodeficient (SCID) mice that lack B-
and T-lymphocytes are challenged with P. gingivalis, there
is considerably less bone resorption than in wild-type
normal mice (114). Moreover, (SCID) mice engrafted with
human CD4() T-cells from individuals with aggressive
early onset periodontal disease and subsequently chal-
lenged with A. actinomycetemcomitans exhibit enhanced
periodontal bone loss (46). This bone loss is mediated by
RANKL. Similarly, the adoptive transfer of B-cells from
A. actinomycetemcomitans immunized rats followed by an
injection of A. actinomycetemcomitans into the gingiva,
stimulates greater alveolar bone resorption than control
mice that have received B-cells from non-immunized mice
(59). The increased resorption was shown to be RANKL
mediated (59). The results of these experiments indicate
that cells of the adaptive immune response significantly
contribute to periodontitis.
In addition to Th1 and Th2 CD4 lymphocytes, there
are two other T-cell subsets that have been identified, Th17
and Tregs (regulatory T-cells). The Th17 lymphocytes
produce IL-17, which in turn stimulate RANKL-mediated
osteoclastogenesis (115). They have been implicated in
rheumatoid arthritis, periodontal disease, and loosening
of joint prostheses (115). Under experimental conditions,
IL-17 appears to have an important protective function
since genetic deletion of IL-17 receptors enhance period-
ontal bone loss stimulated by P. gingivalis in vivo (116).
This may be due to the role of IL-17 in stimulating
chemokines that induce recruitment of neutrophils. How-
ever, humans with periodontitis have increased levels of
Th17 cells and IL-17 mRNA, compared to healthy tissues
suggesting but not proving that IL-17 contributes to
the destructive process (117). The Tregs modulate activa-
tion, proliferation, and effector function of conventional
T-cells (118) and have been identified in periodontal
tissues (119121). Because they are associated with
the production of IL-10, TGF-b, and the inhibitory










Fig. 4. The role of coupling in periodontal lesion development. Bone formation occurs after bone resorption so that the two
processes are coupled. Thus, the resorption pit is occupied by osteoblasts that form new bone. In a normal healthy individual,
the amount of bone formed equals the amount resorbed. In pathologic bone resorption, the amount of bone that forms is less
than that resorbed so that there is net bone loss. This may be due to the impact of inflammation on bone formation.
Inflammation could potentially interfere with coupling by reducing proliferation of osteoblast precursors, inhibiting
differentiation of osteoblasts, decreasing osteoblast numbers by stimulating apoptosis, or by interfering with the production
of bone matrix.
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Uncoupled bone formation and periodontitis
Bone remodeling involves a process of bone resorption
followed by bone formation, a process referred to as
coupling (122). Bacteria induced bone resorption in a
healthy adult should be followed by an equivalent
amount of bone formation. In periodontitis, there is a
failure to form an adequate amount of new bone
following resorption resulting in net bone loss. Thus, a
critical aspect of periodontitis is uncoupling so that
bacteria induced bone loss is not followed by an
equivalent amount of new bone formation resulting in
net bone loss. The impact of uncoupling on creating net
bone loss is shown in Fig. 4.
The same process that stimulates bone resorption,
inflammation, may be responsible for uncoupling. It is
possible that under conditions where inflammation is in
close proximity to and along the bone, it will affect
osteoblast numbers or function and interfere with the
coupling process. In an experimental model, the injection
of P. gingivalis into connective tissue induces bone
resorption followed by bone formation (123, 124). If
the inflammation is prolonged by induction of the
adaptive immune response, the capacity to form
new bone is diminished and uncoupling occurs (123).
Similarly, prolonged inflammation in diabetic animals
interferes with bone formation in the periodontium
following bacteria stimulated bone resorption (124).
This interpretation is additionally supported by evidence
that the application of cytokines in vivo stimulates bone
resorption but also limits bone formation. Therefore,
several lines of animal experimentation support the
concept that inflammation uncouples bone formation
from bone resorption. Thus, inflammation may not only
stimulate the formation of osteoclasts and bone resorp-
tion, but also affect bone by altering the function of
osteoblasts and limiting reparative bone formation.
Conclusions
Polymicrobial infection in lesions of endodontic origin
stimulates bone resorption by interacting with the
leukocytes of the innate and adaptive immune responses.
In endodontic lesions, the presence of inflammation
suppresses bone formation so that lesion resolution
does not occur until the causal bacteria are entombed
by treatment and the inflammation subsides. Period-
ontitis is caused by a host response to the presence of
bacteria or their products that invade connective tissue.
The host defense, including innate and adaptive immu-
nity, is responsible for combating bacteria invading the
periodontal tissue. In humans, plaque accumulation
occurs even in health so that there is a continuous state
of inflammation in gingival tissue adjacent to teeth. By
using animal models and specific inhibitors, both the
innate and adaptive immune response have been conclu-
sively shown to participate in the formation of period-
ontal lesions. Cytokines generated that induce osteolytic
lesions are shown in Fig. 2 and a comparison of the effect
of cytokine deletion or inhibition in the formation of
lesions of endodontic origin and in periodontitis is shown
in Table 2. It is also possible that the inflammation
associated with periodontal bone resorption affects
coupled bone formation contributing to net bone loss
(see Fig. 4).
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